Extended Data Fig. 9: Experimental details for MPRA performed with 11 disease-associated enhancers.
From: Affinity-optimizing enhancer variants disrupt development
Eleven disease-associated enhancers tested in saturation mutagenesis MPRAs; table modified from a previous study30. Two different MYC enhancers were assayed. UC88 is an ultraconserved enhancer. The MPRA for each enhancer is performed within cell lines relevant to the disease studied, as detailed.
